Behavioral Effects of Omega-3 Fatty Acid Supplementation in Young Adults with Severe Autism: An Open Label Study

Archives of Medical Research

Volumn 39, Issue 7, 2008, Pages 682-685

  Politi, Pierluigi ^a   Cena, Hellas ^a   Comelli, Mario ^a   Marrone, Gaetano ^a   Allegri, Chiara ^a   Emanuele, Enzo ^a   Ucelli di Nemi, Stefania ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Autism; Behavior; Omega 3 fatty acids

Indexed keywords

ALPHA TOCOPHEROL; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ADULT; ARTICLE; AUTISM; BEHAVIOR; BEHAVIOR DISORDER; CHECKLIST; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; AUTISTIC DISORDER; BEHAVIOR; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE;

EID: 49949109533     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2008.06.005     Document Type: Article

References (14)

1. Sigman M., Spence S.J., and Wang A.T. Autism from developmental and neuropsychological perspectives. Annu Rev Clin Psychol 2 (2006) 327-355
2. Chez M.G., Burton Q., Dowling T., Chang M., Khanna P., and Kramer C. Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability. J Child Neurol 22 (2007) 574-579
3. Dosman C.F., Brian J.A., Drmic I.E., Senthilselvan A., Harford M.M., Smith R.W., et al. Children with autism: effect of iron supplementation on sleep and ferritin. Pediatr Neurol 36 (2007) 152-158
4. Miral S., Gencer O., Inal-Emiroglu F.N., Baykara B., Baykara A., and Dirik E. Risperidone versus haloperidol in children and adolescents with AD: a randomized, controlled, double-blind trial. Eur Child Adolesc Psychiatry 17 (2008) 1-8
5. McDougle C.J., Scahill L., Aman M.G., McCracken J.T., Tierney E., Davies M., et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry 162 (2005) 1142-1148
6. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67 (2006) 1954-1967
7. Amminger G.P., Berger G.E., Schäfer M.R., Klier C., Friedrich M.H., and Feucht M. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry 61 (2007) 551-553
8. Gilbert D.L. Regarding "omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study". Biol Psychiatry 63 (2008) e13
9. Billstedt E., Gillberg I.C., and Gillberg C. Autism in adults: symptom patterns and early childhood predictors. Use of the DISCO in a community sample followed from childhood. J Child Psychol Psychiatry 48 (2007) 1102-1110
10. Seltzer M.M., Shattuck P., Abbeduto L., and Greenberg J.S. Trajectory of development in adolescents and adults with autism. Ment Retard Dev Disabil Res Rev 10 (2004) 234-247
11. Rellini E., Tortolani D., Trillo S., Carbone S., and Montecchi F. Childhood Autism Rating Scale (CARS) and Autism Behavior Checklist (ABC) correspondence and conflicts with DSM-IV criteria in diagnosis of autism. J Autism Dev Disord 34 (2004) 703-708
12. Hawkins K.A., Sullivan T.E., and Choi E.J. Memory deficits in schizophrenia: inadequate assimilation or true amnesia? Findings from the Wechsler Memory Scale-revised. J Psychiatry Neurosci 22 (1997) 169-179
13. Ross B.M., Seguin J., and Sieswerda L.E. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?. Lipids Health Dis 6 (2007) 21
14. Peet M., and Stokes C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs 65 (2005) 1051-1059